US Patent Issued to Technion Research & Development Foundation on July 22 for "Modified aminoglycoside compounds and uses thereof in disabling bacterial ribosome" (Israeli Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,706, issued on July 22, was assigned to Technion Research & Development Foundation Ltd. (Haifa, Israel).

"Modified aminoglycoside compounds and uses thereof in disabling bacterial ribosome" was invented by Timor Baasov (Haifa, Israel), Boris Smolkin (Ness Ziona, Israel), Alina Khononov (Haifa, Israel), Michal Shavit Kishkober (Matan, Israel) and Valery Belakhov (Haifa, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Modified aminoglycoside compounds represented by Formula I as defined and described in the specification are provided. The modified aminoglycosides feature a diamine-containing functional moiety at one or more of positions 3', 4' a...